The pharmaceutical industry's relationship with contract research organizations has quietly evolved from a cost-cutting arrangement into a structural dependency. The global pharmaceutical CRO market was valued at USD 45.3 billion in 2024 and is projected to reach USD 83.3 billion by 2033, growing at a CAGR of 8.0% from 2026 to 2033. Behind these numbers sits a deeper story: drug...